Dogwood Therapeutics, Inc. (DWTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.43M
Last updated: Nov 17, 2026 at 11:01 AM ET
Dogwood Therapeutics, Inc. (DWTX) Earnings: Report Dates and Results
Dogwood Therapeutics (DWTX) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, Dogwood Therapeutics reported EPS of -$0.14, above the -$0.15 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DWTX has an expected report date of Mar 16, 2027.
Earnings History
Of the 21 quarters below that had an estimate, DWTX beat 13, missed 6 and matched 2. The widest gap in the table came in the quarter ended Sep 30, 2025, when EPS landed 418.99% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.14 | -$0.15 | -$0.16 - -$0.15 | +6.67% | Beat | N/A | 2 | 0 up, 2 down | Nov 5, 2026 |
| Jun 30, 2026 | -$0.34 | -$0.13 | -$0.15 - -$0.13 | -161.54% | Miss | N/A | 3 | 2 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$0.15 | -$0.20 | -$0.30 - -$0.13 | +25.00% | Beat | N/A | 3 | 1 up, 0 down | May 14, 2026 |
| Dec 31, 2025 | -$0.26 | -$0.86 | -$2.00 - -$0.14 | +69.77% | Beat | N/A | 3 | 1 up, 0 down | Mar 18, 2026 |
| Sep 30, 2025 | -$8.20 | -$1.58 | -$2.30 - -$0.45 | -418.99% | Miss | N/A | 3 | 1 up, 0 down | Nov 6, 2025 |
| Jun 30, 2025 | -$1.99 | -$1.90 | N/A | -4.74% | Miss | N/A | N/A | N/A | Aug 13, 2025 |
| Mar 31, 2025 | -$8.45 | -$0.76 | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$6.29 | -$0.06 | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Feb 26, 2025 |
| Sep 30, 2024 | -$2.05 | -$1.18 | N/A | -73.73% | Miss | N/A | N/A | N/A | Nov 7, 2024 |
| Jun 30, 2024 | -$1.25 | -$1.58 | N/A | +20.89% | Beat | N/A | N/A | N/A | Aug 8, 2024 |
| Mar 31, 2024 | -$1.75 | -$1.00 | N/A | -75.00% | Miss | N/A | N/A | N/A | May 9, 2024 |
| Dec 31, 2023 | -$0.06 | -$0.06 | N/A | 0.00% | In line | N/A | N/A | N/A | Feb 29, 2024 |
| Sep 30, 2023 | -$1.50 | -$2.25 | N/A | +33.33% | Beat | N/A | N/A | N/A | Nov 13, 2023 |
| Jun 30, 2023 | -$2.00 | -$1.25 | N/A | -60.00% | Miss | N/A | N/A | N/A | Aug 10, 2023 |
| Mar 31, 2023 | -$0.08 | -$0.16 | N/A | +50.00% | Beat | N/A | N/A | N/A | May 11, 2023 |
| Dec 31, 2022 | -$2.75 | -$3.75 | N/A | +26.67% | Beat | N/A | N/A | N/A | Mar 31, 2023 |
| Sep 30, 2022 | -$7.00 | -$11.50 | N/A | +39.13% | Beat | N/A | N/A | N/A | Nov 14, 2022 |
| Jun 30, 2022 | -$11.00 | -$12.25 | N/A | +10.20% | Beat | N/A | N/A | N/A | Aug 11, 2022 |
| Mar 31, 2022 | -$12.00 | -$13.75 | N/A | +12.73% | Beat | N/A | N/A | N/A | May 12, 2022 |
| Dec 31, 2021 | -$0.54 | -$0.54 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 31, 2022 |
| Sep 30, 2021 | -$12.25 | -$17.25 | N/A | +28.99% | Beat | N/A | N/A | N/A | Nov 11, 2021 |
| Jun 30, 2021 | -$12.75 | -$13.75 | N/A | +7.27% | Beat | N/A | N/A | N/A | Aug 12, 2021 |
| Mar 31, 2021 | -$9.25 | -$23.25 | N/A | +60.22% | Beat | N/A | N/A | N/A | May 13, 2021 |
| Dec 31, 2020 | -$1.25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 |
| Sep 30, 2020 | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 18, 2020 |
| Jun 30, 2020 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 28, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$18.90, after -$11.34 the year before. It was -$1.68 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$18.90 | N/A |
| Dec 31, 2024 | -$11.34 | N/A |
| Dec 31, 2023 | -$3.64 | N/A |
| Dec 31, 2022 | -$32.75 | N/A |
| Dec 31, 2021 | -$34.79 | N/A |
| Dec 31, 2020 | -$1.68 | N/A |
Frequently Asked Questions About DWTX
When is Dogwood Therapeutics's next earnings date?
Dogwood Therapeutics's next earnings report is expected for Mar 16, 2027.
Did DWTX beat earnings estimates last quarter?
Yes. Dogwood Therapeutics reported EPS of -$0.14 for the quarter ended Sep 30, 2026, above the -$0.15 estimate, a 6.67% surprise.
What EPS do analysts expect from DWTX next quarter?
The consensus EPS estimate for Dogwood Therapeutics for the quarter ending Dec 31, 2026 is -$0.16 from 4 analysts.
How often does DWTX beat earnings estimates?
Dogwood Therapeutics beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -67.08%.
DWTX pages: Overview, Earnings, Forecast, Financials, Competitors